Xpamac Inc.

Xpamac Inc. is at the forefront of biotechnology research, dedicated to extending the boundaries of protein therapies. With a focus on cell line development, Xpamac Inc. provides advanced services for the biotech industry, creating next-generation mammalian cell lines designed for efficient, stable, and scalable production of therapeutic proteins. The company's proprietary platform, built on "Mammalian Elongated Chromosomes," enables high-yield expression of complex biologics, including monoclonal antibodies and other difficult-to-express proteins.

Xpamac technology integrates expression cassettes into genomic "safe harbor" regions, allowing precise control of transgene copy numbers and amplification. This leads to accelerated cell line development, long-term protein expression stability, and significantly increased protein yield compared to traditional gene integration methods. Xpamac Inc. is committed to supporting partners in overcoming manufacturing bottlenecks in biologics development, making them a trusted innovation partner in the evolving biologics manufacturing landscape.

Xpamac Inc. actively expands its international collaborations with biopharma companies and CDMOs partners, ensuring it remains at the cutting edge of biotechnological advancements. Discover how Xpamac Inc. can enhance your protein therapy development and manufacturing processes. We invite the manager of Xpamac Inc. to create a customized and exclusive company showcase and product listing on our platform.